한국보건의료기술평가학회
 
 
 

Table of Contents | Vol. 2  No.1 4 2014 Archive

In this issue:






Vol 2, No 1
Editorial
Digitizing Human Beings & Personalized Medicine
Guk-Hee Suh, MD, PhD
Editor-in-Chief, JoHTA; Professor, Hallym University School of Medicine, Korea
J Health Tech Assess 2014;2(1):1-5
Guest Editorial
Current Issues in Pharmacoeconomic Modeling
Joel W. Hay, PhD
Professor, Pharmaceutical Economics and Policy, Schaeffer Center for Health Policy and Economics, University of Southern California, USA
J Health Tech Assess 2014;2(1):6-9
Original Article
Awareness of Medical Academic Societies, Consumer Organizations and Others Including Special Interest Groups and Institutes in Healthcare Sector Concerning the Pay-for-Performance in Korea
Hyeon-Jeong Lee, MPH1, Jin Yong Lee, PhD2, Sang-il Lee, PhD1, Woo-Seung Son, MPH1, Minsu Ock, MPH1, and Min-Woo Jo, PhD1
1Department of Preventive Medicine, University of Ulsan College of Medicine, Seoul, Korea 2Public Health Medical Service, Seoul National University Boramae Medical Center, Seoul, Korea
J Health Tech Assess 2014;2(1):10-18
Citizen Participation in the Healthcare Decision-Making Process: Review of Real Cases
Hae Sun Suh, PhD1,2 and Boram Lee, MPH2,3
1College of Pharmacy, Pusan National University, Busan, Korea 2Research and Development Center, Health Insurance Review & Assessment Service, Seoul, Korea 3Graduate School of Public Health, Seoul National University, Seoul
J Health Tech Assess 2014;2(1):19-25
Cost-Effectiveness of Single-Pill Combination Therapy of Amlodipine/Atorvastatin Compared with Concurrent Two-Pill Therapy in Patients with Hypertension in Korea
Young-Joo Kim, MS1, Su-Kyoung Ko, MPH, PhD1, and Cheol-Whan Lee, MD2
1Pfizer Pharmaceuticals Korea Ltd., Seoul, Korea 2Department of Cardiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
J Health Tech Assess 2014;2(1):26-34
Methods on Improvement of Accessibility for Rare Disease Treatments: Providers’ Perspective
Ji Yeon Lee1, Yeong Mi Cho1, Sung Tae Kim2, and Sung Ju Kim1
1Regulatory Affairs & Market Access, Genzyme Korea, Seoul, Korea 2KIM & CHANG, Seoul, Korea
J Health Tech Assess 2014;2(1):35-42
Review Article
Comparative Study on Budget Impact Analysis Guideline of Canada, Poland, Belgium and Ireland
Seong-Ok Kim, PhD1 and Sang-Eun Choi, PhD2
1Health Insurance Policy Research Institute, National Health Insurance Service, Seoul, Korea 2College of Pharmacy, Korea University, Sejong, Korea
J Health Tech Assess 2014;2(1):53-63
Diagnostic Tests for Anaplastic Lymphoma Kinase Gene Rearrangement in Non-Small-Cell Lung Cancer
HyunJoo Oh, PhD1 and Dawoon Kim2
1Department of Health Policy & Administration, Inje University, Gimhae, Korea 2Medical School, Chonnam University, Gwangju, Korea
J Health Tech Assess 2014;2(1):64-67
Decision Making Based on Incremental Cost-Effectiveness Ratio for Anticancer Drugs
Hoe Sang Kim, MS1, Young-Ju Kang, MS2, Su-Kyung Ko, PhD3, and Hye-Young Kang, PhD4
1Jongno-gu Public Health Center, Seoul, Korea 2The Korean Research-Based Pharmaceutical Industry Association, Seoul, Korea 3Pfizer Korea, Seoul, Korea 4College of Pharmacy, Yonsei Research Institute of Pharmaceu
J Health Tech Assess 2014;2(1):68-73
Research Agenda Setting Processes in the US and UK Health Technology Assessment Institutions
Min-Jeong Kim, PhD, Shinhee Kang, PhD, and Chong Yon Park, PhD
National Evidence-based Healthcare Collaborating Agency, Seoul, Korea
J Health Tech Assess 2014;2(1):43-52
Case Report
Case Report of Platelet-Rich Plasma in Patients with Bone Graft at Implant Surgery
WonBae Cho1 and HyunJoo Oh, PhD2
1Kyung Won Dental Clinic, Seoul, Korea 2Department of Health Policy & Administration, Inje University, Gimhae, Korea
J Health Tech Assess 2014;2(1):74-77


 
개인정보취급방침 05505 서울 송파구 올림픽로 43길 88 아산생명과학연구원 2관 2층 예방의학교실 02-3010-4257 kahta@hanmail.net
Copyright 2015 KAHTA All Rights Reserved.